/EIN News/ — LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) — Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious … Read More
The post Vitality Biopharma CEO Robert Brooke Provides Shareholder Letter appeared first on Dagga Magazine.